CDKN2A (Figure 1B(Fig. 1)), which is often mutated in a variety of cancers, exhibited hypermethylation in the 1N group (adj.p = 0.006), while it was hypomethylated in 2N group in comparison to 0N group (adj.p = 0.008). Here, CDKN2A is linked to cancer.